Biological Information
Background Information:
Androgen receptors are members of a superfamily of nuclear receptors that transduce the effects of a diverse array of small, hydrophobic ligands, including the steroid hormones, thyroid hormone, vitamin D and retinoids.
Family:
NHR
Sub Family:
3-Ketosteroid
Class:
Steroid
Protein Name:
AR
Uniprot Number:
P10275
Protein Aliases:
testicular feminization|Kennedy disease
Gene Name:
AR
Gene ID:
367
Gene Aliases:
AIS|NR3C4|SMAX1|HUMARA
Accession Number:
NM_000044
Organism:
Human
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Binding
Detection Method:
Radiometry
Measured Response:
Scintillation
Testing Information
Procedure Summary:
Human androgen receptors obtained from human LNCaP cells are used in modified HEPES buffer pH 7.4. A 70 µg‡ aliquot is incubated with 0.5 nM [³H]Methyltrienolone for 20 hours at 4°C. Non-specific binding is estimated in the presence of 1 µM Methyltrienolone. Receptors are filtered and washed. The filters are then counted to determine [³H]Methyltrienolone specifically bound. Compounds are screened at 10 µM. ‡The concentration used will be adjusted if necessary.
Ligand:
[³H] Methyltrienolone
Ligand Kd (nM):
0.71
Ligand Concentration:
0.5 nM
Non Specific:
1 µM Testosterone
Incubation:
1200 min at 4°C
Control Inhibitor:
Testosterone
Criteria For Significance:
≥ 50% of max stimulation or inhibition
Test Concentration / Dose:
Suggested concentration for initial testing is 10 uM
Test Sample Requirements:
Minimum for 1) Screen: 25 μl of 10 mM stock -OR- 1 mg (pre-weighed). 2) Dose Response: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed).
Minimum Order Quantity:
2
Turnaround Time
Standard:
15 Business Days
Reference Compound Data
Clinical Relevance
Therapeutic Area:
Metabolic Diseases
Adverse / Beneficial Action:
Androgen receptor agonists may promote prostate cancer and cause edema while antagonists may inhibit spermatogenesis and be useful in the treatment of prostate cancer.
Additional Information
Brand:
LeadHunter
Testing Location:
Taiwan - Taipei
RELATED SOLUTIONS